Nystagmus: an update on treatment in adults.
Recent developments in the treatment of nystagmus in adults have changed the traditional approach to such illnesses as benign paroxysmal positional vertigo, vestibular neuritis, Meniere's disease, superior canal dehiscence syndrome, vestibular paroxysmia, superior oblique myokymia, downbeat/upbeat nystagmus and acquired pendular nystagmus, as well as periodic alternating nystagmus. Treatments reported to suppress nystagmus, with tolerable side effects, are now available for some of these syndromes. Due to the absence of large controlled studies, however, treatment recommendations rest only on class C evidence.
Straube
Andreas
A
Department of Neurology, Klinikum Grosshadern, University of Munich, Marchioninistrasse 15, 81377 Munich, Germany. astraube@nefo.med.uni-muenchen.de
D000328:Adult; D003348:Cortisone / Q000627:therapeutic use; D006801:Humans; D008575:Meniere Disease / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D009759:Nystagmus, Pathologic / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D026902:Potassium Channel Blockers / Q000627:therapeutic use; D015837:Vestibular Diseases / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology
D004364:Pharmaceutical Preparations; D026902:Potassium Channel Blockers; D003348:Cortisone